Loading...
ASP Isotopes Inc. Common Stock
ASPI•NASDAQ
Basic MaterialsChemicals
$9.36
$0.60(6.85%)
ASP Isotopes Inc. Common Stock (ASPI) Stock Overview
Explore ASP Isotopes Inc. Common Stock’s financial performance, market position, analyst ratings, and future outlook.
Revenue Growth
857.04%
↑ 857.04%
Profit Growth
$-0.46
↓ 98.53%
EPS Growth
$-0.46
↓ 8.16%
Operating Margin
-635.91%
↓ 64.28%
ROE
-119.62%
↓ 98.53%
Dividend Yield
0.00%
Analyst Recommendations
Strong Buy
Buy
Hold
Sell
Strong Sell
Price Targets
Low$4.50
Average$4.50
High$4.50
Company Profile
ASP Isotopes Inc., a pre-commercial stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It develops Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company also Uranium-235, an isotope of uranium for carbon-free energy industry. ASP Isotopes Inc. was incorporated in 2021 and is based in Boca Raton, Florida.
CEO
Mr. Paul Elliot Mann C.F.A.
Employees
136
Headquarters
433 Plaza Real, Washington, FL
Founded
2022